Get news alerts by email

Astellas is committed to providing timely and accurate information about our business, science and products. If you're an investor, journalist or media professional and are interested in receiving Astellas breaking news via email, please fill out the form below and you will receive an e-mail each time we send out a new release. The release will come to your email as body text within the message. You will receive an email that you must reply to in order to confirm your subscription. You may unsubscribe from our list at any time. You can view our global privacy policy here.

Alerts are intended for investors and journalists only. News releases included in an email alert that contain information about pharmaceutical products (including products currently in development) are not intended to constitute an advertisement or medical advice. Alert distribution is at Astellas’ discretion. There may be instances where distribution does not occur.

Thank you for your interest in Astellas.

If you are not an investor or journalist, click here.